Solventum Corporation (SOLV) DCF Valuation
Two independent models estimate Solventum Corporation's fair value between $67.07 (conservative case) and $141.97 (analyst consensus).
What would today's price require?
$79.22 is justified only if free cash flow grows about +6.7% a year for the next decade — faster than the company has actually grown.
Current Price
$79.22
Fair-Value Range
$67.07 – $141.97
Market-Implied Growth
+6.7%/yr
vs -25.2% 5Y actual
SOLV DCF Fair Value Calculator
Edit the assumptions to see how they change the estimated fair value. Illustrative model — not investment advice. Defaults to a conservative base case; the analyst (FMP) DCF, where available, is shown as a reference below.
Base inputs: FCF $962.0M · 0.17B shares · net debt $4.2B
Estimated Fair Value
$67.07
-15.3% vs $79.22
Sensitivity — fair value by discount rate × terminal growth
How the estimated fair value shifts with the discount rate (WACC) and terminal growth, holding your 5.0%/yr FCF growth and 10-year horizon fixed. Green = above today's $79.22; red = below. Your current case is outlined.
| WACC ↓ / Terminal → | 1.50% | 2.00% | 2.50% | 3.00% | 3.50% |
|---|---|---|---|---|---|
| 8.0% | $89.18 | $94.98 | $102 | $110 | $120 |
| 9.0% | $73.21 | $77.18 | $81.76 | $87.10 | $93.41 |
| 10.0% | $61.05 | $63.87 | $67.07 | $70.72 | $74.94 |
| 11.0% | $51.49 | $53.56 | $55.87 | $58.47 | $61.42 |
| 12.0% | $43.78 | $45.34 | $47.05 | $48.96 | $51.10 |
About Solventum Corporation
Solventum Corporation, established in 2023 and headquartered in Saint Paul, Minnesota, operates as a healthcare entity dedicated to pioneering, producing, and commercializing diverse solutions that address critical needs for both customers and patients. The company's business activities are organized into four principal segments. The Medsurg division furnishes various products and services, including sophisticated wound care items, intravenous (I.V.) site management tools, sterilization assurance systems, temperature regulation devices, surgical instruments, stethoscopes, and medical electrodes. Its Dental Solutions segment provides a comprehensive range of dental and orthodontic offerings, such as brackets, clear aligners, restorative filling materials, and bonding agents. The Health Information Systems division concentrates on advanced software platforms, covering functionalities like computer-assisted physician documentation, direct billing and coding automation, classification frameworks, voice recognition capabilities, and data visualization tools. Finally, the Purification and Filtration segment supplies an array of purification and filtration technologies, including various filters, purifiers, cartridges, and specialized membranes.
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- CEO
- Bryan C. Hanson